Vicore Pharma AB Employee Directory
Pharmaceutical ManufacturingStockholm, Sweden51-200 Employees
Vicore Pharma AB is a mid-sized clinical-stage biopharmaceutical company focused on developing disease-modifying medicines for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its lead program, buloxibutid, is an oral small-molecule agonist of the angiotensin II type 2 receptor and is currently in a global 52-week Phase 2b trial in IPF. Based in Stockholm, Stockholm County, Vicore is publicly listed on Nasdaq Stockholm under ticker VICO. The company engages with the broader scientific community through conferences and presentations, and in May 2026 elected Peter Guenter to its board of directors.